Dr. Kamelhar is Principle Investigator involving investigation of cough as it relates to the voice box and reflux-related disorders. He is as well Principle Investigator of a pioneering multi-institution study regarding the course of active non-tuberculous mycobacterial infection (NTM) managed with measures other than medication.
Additional interests include the involvement of esophageal disorders and alterations in the natural bacterial population (microbiome) in the course of mycobacterial infection and bronchiectasis.
Dr. Kamelhar has been identified by his peers as one of the "Top Doctors in New York Metropolitan Area" and "America's Best Doctors" since 1997 as published by Castle Connolly Associates. Dr. Kamelhar has received the American Medical Association's Physician Recognition Award.
